Summary
Yale University (Yale) is a research and educational institution that provides educational programs and educational courses. The institution provides courses such as graduate, undergraduate, professional and distance learning programs, and summer courses. Its academic programs offers African American studies, anesthesiology, anthropology, applied mathematics, applied physics, astronomy, cell biology, classics, African studies, Agrarian studies, biological and biomedical sciences, biostatistics, British studies, chemistry, comparative literature, and dermatology, and others. The institution also provides courses in drama, engineering, divinity, music, art, architecture, forestry and environmental studies, law, management, and medicine. Yale is headquartered in New Haven, Connecticut, the US.
Yale University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Yale University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Yale University, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Yale University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Yale University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Yale University, Medical Devices Deals, 2010 to YTD 2016 9
Yale University, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Yale University, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
IsoPlexis Raises USD1.3 Million in Series A Financing 12
New Haven Pharma Raises US$7 Million In Series A Financing 13
Partnerships 15
Organovo Enters into Co-Development Agreement with Yale School of Medicine 15
GlaxoSmithKline Enters into Partnership with Yale University 16
Evotec Enters Into Research Agreement With Yale University For Cancer Therapy 17
Novogen Forms Joint Venture With Yale University 18
CaroGen Enters into Research Agreement with Yale University 20
GlaxoSmithKline Enters Into Co-Development Agreement With Yale University 21
Unigene Labs Terminates Research And License Agreement With Yale University 22
Amway Enters Into Co-Development Agreement With Yale University 23
Gilead Sciences Enters Into Research Collaboration With Yale School of Medicine 24
Licensing Agreements 26
Patrys Enters into Licensing Agreement with Yale University 26
Allied-Bristol Life Sciences Enters into Licensing agreement with Yale University 27
Debiopharm Enters Into Licensing Agreement With Yale University 28
CaroGen Enters into Licensing Agreement with Yale University 30
Medistem Enters Into Licensing Agreement With Yale University For Type 1 Diabetes 31
Debiopharm Enters Into Licensing Agreement With Yale University For Debio 1036 32
Yale University - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Yale University, Pharmaceuticals & Healthcare, Key Facts 1
Yale University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Yale University, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Yale University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Yale University, Deals By Therapy Area, 2010 to YTD 2016 8
Yale University, Medical Devices Deals, 2010 to YTD 2016 9
Yale University, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
IsoPlexis Raises USD1.3 Million in Series A Financing 12
New Haven Pharma Raises US$7 Million In Series A Financing 13
Organovo Enters into Co-Development Agreement with Yale School of Medicine 15
GlaxoSmithKline Enters into Partnership with Yale University 16
Evotec Enters Into Research Agreement With Yale University For Cancer Therapy 17
Novogen Forms Joint Venture With Yale University 18
CaroGen Enters into Research Agreement with Yale University 20
GlaxoSmithKline Enters Into Co-Development Agreement With Yale University 21
Unigene Labs Terminates Research And License Agreement With Yale University 22
Amway Enters Into Co-Development Agreement With Yale University 23
Gilead Sciences Enters Into Research Collaboration With Yale School of Medicine 24
Patrys Enters into Licensing Agreement with Yale University 26
Allied-Bristol Life Sciences Enters into Licensing agreement with Yale University 27
Debiopharm Enters Into Licensing Agreement With Yale University 28
CaroGen Enters into Licensing Agreement with Yale University 30
Medistem Enters Into Licensing Agreement With Yale University For Type 1 Diabetes 31
Debiopharm Enters Into Licensing Agreement With Yale University For Debio 1036 32
Yale University, Key Competitors 33
Yale University, Key Employees 34
Yale University, Subsidiaries 35
List of Figures
Yale University, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Yale University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Yale University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Yale University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Yale University, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Yale University, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Yale University, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Yale University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Yale University, Medical Devices Deals, 2010 to YTD 2016 9
